spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  optical coherence tomography 

 HSMN NewsFeed - 7 May 2021
LumiThera Presents Valeda Treatment Benefits for Photobiomodulation in Early Patients with Diabetic Retinopathy and Macular Edema
Devices Ophthalmology
 HSMN NewsFeed - 25 Sep 2019
OrbusNeich(R) Announces Japan Approval for COMBO(R) Plus Coronary Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 20 Mar 2019
Optovue Launches New AngioWellness(TM) Scan at Vision Expo East
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 25 Jul 2017
Roxwood Medical Announces Agreement with Abbott for Distribution of Products in U.S.
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 16 May 2017
Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience
Devices Interventional Cardiology
 HSMN NewsFeed - 3 May 2016
NinePoint Medical Strengthens Sales Leadership by appointing John Temple as Vice President of Sales
Devices Personnel
 HSMN NewsFeed - 11 Jan 2016
MedLumics Appoints Cardiovascular Device Expert Tim Lenihan to Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 21 May 2015
Ampio Pharmaceuticals Announces Positive Study Results on Optina(TM) for the Treatment of Diabetic Macular Edema
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 4 Dec 2014
NinePoint Medical Appoints Christopher von Jako, Ph.D., to Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 18 Sep 2014
Latest Data Shows OrbusNeich's COMBO(TM) Dual Therapy Stent has Excellent Healing Benefits
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Jun 2014
Allergan Announces R&D Pipeline Update and U.S. FDA Approval; Company to Host Conference Call Today, Monday, June 30th at 10:30 AM ET
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 20 May 2014
STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2014
Elixir Medical Receives CE Mark Approval for the Breakthrough Fully Bioresorbable DESolve(R) 100 Novolimus Eluting Coronary Scaffold System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 20 Mar 2014
NinePoint Medical Completes $34 Million Series B Financing to Expand Commercialization of its Breakthrough NvisionVLE(TM) Imaging System
Devices Venture Capital
 HSMN NewsFeed - 14 Nov 2013
Svelte Medical Systems Announces Enrollment Complete in the DIRECT II Drug-Eluting Stent Study
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Oct 2013
Elixir Medical Announces Excellent 1-Year Safety and Efficacy Results for the CE-Marked Fully Bioresorbable DESolve(R) Novolimus Eluting Coronary Scaffold System
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Jul 2013
Abbott to Enter Laser Cataract Surgery Market through Acquisition of OptiMedica
Devices Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 30 May 2013
Orsiro From BIOTRONIK, Industry's First Hybrid Drug-Eluting Stent, Performs as Best in Class
Devices Interventional Cardiology
 HSMN NewsFeed - 23 May 2013
Svelte Drug-Eluting Stent Utilizing New Class of Bioabsorbable Drug Coating Attains 0% Clinically-Driven Events Through 12-Months in First-In-Man Study
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2013
St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 26 Apr 2013
NinePoint Medical Receives Additional FDA 510(k) Clearance for NvisionVLE Imaging System
Devices FDA
 HSMN NewsFeed - 11 Mar 2013
St. Jude Medical Announces Launch of 3-D Vessel Reconstruction Technology in Japan
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Jan 2013
Svelte Medical Systems Announces Treatment of First Patient in the DIRECT II Drug-Eluting Stent Study
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Jan 2013
OrbusNeich's COMBO Dual Therapy Stent(TM) to Be Featured During AsiaPCR/SingLIVE 2013 Symposium
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Dec 2012
Avinger Receives FDA Clearance for Ocelot / PIXL
Devices Interventional FDA
 HSMN NewsFeed - 18 Dec 2012
St. Jude Medical Enrolls First Patient in ILUMIEN I Study to Develop Guidance for Stent Optimization
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Nov 2012
Avinger’s Ocelot System is FDA Cleared
Devices Interventional FDA
 HSMN NewsFeed - 16 Oct 2012
OrbusNeich's COMBO Dual Therapy Stent(TM) to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Oct 2012
Avinger To Reveal CONNECT II Clinical Trial Results for First-Ever Imaging CTO Catheter To Help Save PAD Patients’ Legs
Devices Interventional
 HSMN NewsFeed - 10 Jul 2012
Avinger Raises $33 Million in Series D Financing
Devices Interventional Venture Capital
 HSMN NewsFeed - 17 May 2012
Early Coronary Artery Healing Advantage of OrbusNeich's Combo Dual Therapy Stent(TM) Compared to the TAXUS(R) Stent Shown in Two Clinical Trial Subgroup Analyses
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2012
Elixir Medical Announces Excellent Results from DESolve I First-In-Man Study for the Fully Bioresorbable Drug Eluting Coronary Scaffold System
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Jan 2012
NinePoint Medical Receives FDA 510(k) Clearance for Nvision VLE Imaging System
Devices FDA
 HSMN NewsFeed - 26 Oct 2011
St. Jude Medical Announces FDA Clearance of First and Only Combined FFR and OCT System
Devices Cardiology FDA
 HSMN NewsFeed - 7 Sep 2011
OptiMedica Receives CE Mark for Catalys(TM) Precision Laser System
Devices Ophthalmology Regulatory
 HSMN NewsFeed - 14 Jul 2011
St. Jude Medical Announces European Approval of First and Only Combined FFR and OCT System
Devices Interventional Cardiology
 HSMN NewsFeed - 12 May 2011
Avinger Receives CE Mark Approval for Its Wildcat Catheter for the Treatment of Peripheral Artery Chronic Total Occlusions and Will Present Results from Its Connect Study at EuroPCR Conference May 17-19
Devices Interventional Regulatory
 HSMN NewsFeed - 25 Feb 2011
Avinger Announces Expansion of Its Sales Force as the Company Plans for Growth in 2011
Devices Interventional
 HSMN NewsFeed - 31 Jan 2011
St. Jude Medical Announces Superior Court Ruling in Trade Secret Lawsuit Involving Its OCT Business and Volcano Corporation and Axsun Technologies
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 18 Jan 2011
Texas Heart(R) Institute at St. Luke’s Episcopal Hospital Cardiologists First in Houston to Use Breakthrough Imaging to Better Diagnose and Treat Patients with Blocked Arteries
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Jan 2011
Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 10 Dec 2010
Tomophase OCTIS(TM) Receives FDA 510(K) Clearance to Market
Devices FDA
 HSMN NewsFeed - 22 Sep 2010
Abbott's Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Sep 2010
Volcano Drives Innovation Forward With Three New U.S. Product Launches at TCT 2010
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Sep 2010
Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 31 Aug 2010
CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Jul 2010
St. Jude Medical Files Patent Infringement Lawsuit Against Volcano Corporation in the U.S.
Devices Cardiology Litigation
 HSMN NewsFeed - 16 Jun 2010
Lantis Laser Signs Letter of Intent to Merge With Perio-Imaging Inc.
Devices Dental Mergers & Acquisitions
 HSMN NewsFeed - 26 May 2010
Volcano Introduces VIBE RX - the World's Only Vascular Imaging Balloon Catheter
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 25 May 2010
Abbott's Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
Devices Interventional Cardiology
 HSMN NewsFeed - 19 May 2010
Volcano Announces 510(k) Clearance, CE Mark Approval, and First Clinical Use for the PrimeWire PRESTIGE(TM) Pressure Guide Wire
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 27 Apr 2010
Volcano Announces Distribution Agreement With AngioScore for the AngioSculpt(R) PTCA Scoring Balloon Catheter in Japan
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 22 Mar 2010
Tomophase Corporation Names Ralph S. Johnston President and Chief Operating Officer
Devices Personnel
 HSMN NewsFeed - 12 Mar 2010
Volcano Expands Access to FFR with Ability to Integrate with the Majority of Hemodynamic Monitoring Systems
Devices Interventional Monitoring
 HSMN NewsFeed - 5 Mar 2010
Stentys self-expanding stent receives CE Marking to treat acute coronary syndrome (ACS)
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 9 Feb 2010
Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter
Devices Interventional Cardiology Acquisitions
 HSMN NewsFeed - 9 Feb 2010
Volcano Receives FDA Clearance to Market the Eagle Eye(R) Platinum Digital IVUS Catheter
Devices Interventional FDA
 HSMN NewsFeed - 12 Jan 2010
Michelson Diagnostics VivoSight(TM) OCT Scanner Receives FDA 510(k) Clearance
Devices FDA
 HSMN NewsFeed - 22 Dec 2009
Volcano Corporation Commends the Elevation of FFR to Level of Evidence A in New PCI Guidelines
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Dec 2009
First patient enrolled in randomized study of Stentys self-expanding stent vs. conventional stent to treat acute myocardial infarction (AMI)
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Sep 2009
Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Sep 2009
Michelson Diagnostics Awarded CE-Mark for Clinical Use of Its VivoSight OCT Scanner in Europe and for Non-Clinical Applications Worldwide
Devices Diagnostics Monitoring Oncology Regulatory
 HSMN NewsFeed - 25 Aug 2009
Volcano Corporation and Siemens Healthcare Announce Global Resale Agreement for Volcano IVUS/FFR Systems
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Aug 2009
Oraya Therapeutics Names Jim Taylor as President and Chief Executive Officer
Devices Ophthalmology Personnel
 HSMN NewsFeed - 15 Jul 2009
Atrium Medical Corporation Announces Release of the Interim Results of the "COCTAIL Study"
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Jul 2009
Volcano Achieves Major Milestone in Japan Direct Sales Initiative With Signing of Termination Agreement With Goodman
Devices Interventional Distribution
 HSMN NewsFeed - 17 Jun 2009
Imalux(R) Names New President/CEO
Devices Personnel
 HSMN NewsFeed - 15 Jun 2009
QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 1 Jun 2009
vProtect(TM) Luminal Shield Stabilizes Vulnerable Plaque
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2009
Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Mar 2009
Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Mar 2009
The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Feb 2009
Imalux(R) Corporation and Preventive Oncology International(R), Inc. Differentiate Grades of Pre-Invasive Cervical Dysplasia with Niris Optical Coherence Tomography Imaging System
Devices Diagnostics Oncology
 HSMN NewsFeed - 20 Jan 2009
Volcano Highlights Commitment, Market Acceptance of FFR Product Line
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Dec 2008
Volcano Announces Acquisition of Axsun Technologies, Inc.
Devices Acquisitions
 HSMN NewsFeed - 15 Oct 2008
Volcano Corporation Announces Launch of PrimeWire(TM) Pressure Guidewire and s5-FFR Option for Existing Fleet of s5 IVUS Consoles
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Oct 2008
Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego
Devices
 HSMN NewsFeed - 15 Sep 2008
Volcano Announces Resignation of Olav Bergheim from Board of Directors
Devices Interventional Personnel
 HSMN NewsFeed - 2 Sep 2008
Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib
Devices Cardiology
 HSMN NewsFeed - 17 Jul 2008
Carl Zeiss Meditec Reaches 1,000 Cirrus(TM) HD-OCT Placements
Devices Ophthalmology
 HSMN NewsFeed - 20 May 2008
MIV's Stents Subject of Two Live Cases and Several Presentations at EuroPCR
Devices Interventional Cardiology
 HSMN NewsFeed - 19 May 2008
Volcano Announces Acquisition of Novelis, Inc.
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 8 May 2008
Volcano Corp Announces First Human Use of the Volcano Optical Coherence Tomography (OCT) Imaging Catheter
Devices Cardiology
 HSMN NewsFeed - 5 May 2008
Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
Devices Interventional
 HSMN NewsFeed - 4 Apr 2008
Carl Zeiss Meditec Delivers Key Technological Advances in Optical Coherence Tomography
Devices Ophthalmology
 HSMN NewsFeed - 28 Mar 2008
Positive results from Visudyne(R) combination therapy study reported at Annual Macula Society Conference
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 28 Mar 2008
Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Mar 2008
GlucoLight Corporation Raises Third Tranche Of ''C'' Round Financing
Devices Monitoring Venture Capital
 HSMN NewsFeed - 14 Feb 2008
GlucoLight Corporation Raises Second Tranche of ''C'' Round Financing
Devices Monitoring Venture Capital
 HSMN NewsFeed - 21 Jan 2008
Super-Thin Drug-Free Coating 'Hides' Stent as It Unblocks Heart Arteries
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Jan 2008
John Moore Appointed to STAAR Surgical Board Of Directors
Devices Ophthalmology Personnel
 HSMN NewsFeed - 18 Dec 2007
Volcano Announces Closing of CardioSpectra Acquisition
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 10 Dec 2007
Volcano Announces Agreement to Acquire CardioSpectra
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 22 Aug 2007
GlucoLight Successfully Completes First Hypoglycemic ''Clamping'' Study of Sentris-100(TM)
Devices Monitoring Endocrinology
 HSMN NewsFeed - 22 May 2007
GlucoLight Corporation Announces Successful Completion of First ICU Clinical Study
Devices Monitoring
 HSMN NewsFeed - 21 May 2007
FoxHollow Provides Update on Regulatory Process for Its NightHawk(TM) System
Devices Interventional FDA
 HSMN NewsFeed - 26 Apr 2007
Imalux Announces Major European Clinical Trials
Devices Radiology Oncology
 HSMN NewsFeed - 2 Apr 2007
FoxHollow Announces FDA 510(k) Submission for the NightHawk(TM) System
Devices Interventional FDA
 HSMN NewsFeed - 25 Jan 2007
Lantis' (LLSR) OCT Dental Imaging System(TM) Will Provide Dentists With Major Upgrade to Chairside Imaging
Devices Dental
 HSMN NewsFeed - 19 Jan 2007
Bioptigen Receives FDA Clearance and Two Phase II SBIR Awards; Company to Exhibit at Major Technology Conference
Devices Ophthalmology
 HSMN NewsFeed - 12 Dec 2006
Serono Announces Initiation of the Reflex Trial to Evaluate New Formulation of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Nov 2006
Carl Zeiss Meditec Announces Installation of 6000th Stratus OCT
Devices Ophthalmology
 HSMN NewsFeed - 7 Nov 2006
Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2007
Devices Biopharmaceuticals Cardiology Oncology Neurology
 HSMN NewsFeed - 12 Sep 2006
OXiGENE to Focus Ophthalmology Strategy Toward Non-Invasive Administration of CA4P for Age-Related Macular Degeneration (AMD)
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 8 Sep 2006
FoxHollow Announces First Patient Treated With the NightHawk(TM) System, a New Technology Enabling Real-Time Visualization During Arterial Plaque Excision in the Lower Legs
Devices Interventional
 HSMN NewsFeed - 26 Jun 2006
OSI Pharmaceuticals and Pfizer Announce Phase IV Macugen(R)(pegaptanib sodium injection) Maintenance Trial in Neovascular Age-Related Macular Degeneration (AMD)
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 1 Jun 2006
Preliminary Topline Efficacy Results from Phase II Data Show Macugen(R) (pegaptanib sodium injection) Maintained or Improved Vision in over 90 Percent of Patients with Macular Edema Associated with Central Retinal Vein Occlusion (CRVO)
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 4 May 2006
OSI Pharmaceuticals Summarizes Macugen(R) (pegaptanib sodium injection) Data Presented at Association for Research in Vision and Ophthalmology (ARVO) Meeting
Biopharmaceuticals Ophthalmology
Return to NewsFeed  

 Additional items found! 17

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 17 additional stories matching:
optical coherence tomography
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.